Can B Corp (CANB)

[sleekscape]

WHY I LIKE CANB

As the only publicly traded company in America producing and selling a full lineup of Pure CBD Oil products, as well as growing and processing hemp for CBD Isolate, CANB is best positioned to deliver a windfall to its investors in 2019-2020 due to the FDA permitting Pure CBD in dietary supplements to sell nationally

Mile High Labs and Medterra are two of the biggest CBD Isolate and Pure CBD product companies in America and both are wildly successful, but neither one is publicly traded, so where else can an investor gain exposure to CBD Isolate and Pure CBD products besides CANB?

Being the only CBD Oil stock in America utilizing the formulation of CBD most likely to be federally legalized by the FDA is certainly the most obvious advantage that CANB has over the rest of the sector:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152129318

But there are several other advantages that CANB possesses, and the following favorable factors are acting synergistically with CANB’s Pure CBD formulation to give it the greatest % gain potential from current prices in the CBD Oil sector:


1. Best financing in the sector

Private Placements at zero discount to market in August (restricted shares)

$4,000,000 raised at $.029

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152131404


2. Most rapid annual revenue growth in the sector

500% revenue growth year-over-year

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151962562


3. Only processor of raw hemp into CBD Isolate (as opposed to Full Spectrum CBD)

That is a unique advantage because CBD Isolate Processing is a huge market, there’s a tremendous lack of processors, and as has already been stated, Pure CBD is likely to be the only formulation to receive FDA approval for national sales

CANB is partnering with Mile High Labs for processing hemp

https://www.milehighlabs.com/


4. Complete vertical integration from seed to sale

CANB is also a grower of hemp as well, so they have achieved complete vertical integration and full control over the entire supply chain from seed to sale, thereby maximizing profit margins

CANB is partnering with Shi Farms for growing hemp

https://www.shifarms.com/


5. The depth and expertise of the corporate and medical advisory boards

8 MDs, 4 attorneys, 1 orthopedic surgeon and a Senator

https://canbiola.com/management-team/


6. Medical Sales

CANB sells to both the retail and medical markets, but they specialize in the sales of CBD Oil products to the medical & healthcare community, which is a far less crowded market


7. No convertible debt

Very rare on the OTC, as this is typically how these companies raise money


8. Potential to uplist to Nasdaq

Canbiola, Inc. (the “Company”) submitted an application to be listed on The Nasdaq Capital Market® on June 4, 2019. The Company intends to diligently pursue its application in order to have its securities listed on the Nasdaq Stock Market.

With a fully independent board of directors and the shareholder equity criteria now met, CANB now has the potential to uplist to the Nasdaq in 2020:

https://www.otcmarkets.com/filing/conv_pdf?id=13484913&guid=yRKSUW-VfXVyW3h


Sleek